Hutchison et al. recently suggested a role of CMV-related T cell immune response in triggering therapy induced hepatitis by demonstrating enrichment of a CMV-associated CD4 TEM population in the periphery of patients who later developed hepatitis [17]. This evidence concerns the gene CD4 and Hepatitis.